Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
3.2 Clinical medicine, Expert, Latvian Council of Science
26 May 2020 → 25 May 2023
3.2 Clinical medicine, Expert, Latvian Council of Science
18 Mar 2017 → 16 Mar 2020
Field of Science
- 3.2 Clinical medicine
Fingerprint
Dive into the research topics where Inga Stuķēna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
PAI-1 level differences in malignant plural effusion, parapneumonic pleuritis, and cardiac hydrothorax
Zentina, D., Stukena, I., Krams, A. & Lejnieks, A., Sept 2019, In: Medicina (Lithuania). 55, 9, 567.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)2 Downloads (Pure) -
Cognitive function in a randomized trial of evolocumab
EBBINGHAUS Investigators, Giugliano, R. P. & Stuķēna, I., 17 Aug 2017, In: New England Journal of Medicine. 377, 7, p. 633-643 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile186 Citations (Scopus)1 Downloads (Pure) -
Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy
APEX Investigators & Stukena, I., 1 Jul 2017, In: Journal of the American Heart Association. 6, 7, e006015.Research output: Contribution to journal › Article › peer-review
Open AccessFile33 Citations (Scopus)34 Downloads (Pure) -
Evolocumab and clinical outcomes in patients with cardiovascular disease
FOURIER Steering Committee and Investigators & Stukena, I., 4 May 2017, In: New England Journal of Medicine. 376, 18, p. 1713-1722 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3351 Citations (Scopus) -
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)
APEX Investigators & Stukena, I., 14 Feb 2017, In: Circulation. 135, 7, p. 648-655Research output: Contribution to journal › Article › peer-review
Open AccessFile46 Citations (Scopus)258 Downloads (Pure)
Activities
- 2 Membership of NGOs
-
Latvian Medical Association (External organisation)
Inga Stuķēna (Member)
2020 → …Activity: Membership types › Membership of NGOs
-
Latvian Internists' Society (External organisation)
Inga Stuķēna (Member)
2020 → …Activity: Membership types › Membership of NGOs